comparemela.com
Home
Live Updates
Muvalaplin, an Oral Small Molecule Inhibitor of Lipoprotein(a) Formation: A Randomized Clinical Trial | Cardiology | JAMA : comparemela.com
Muvalaplin, an Oral Small Molecule Inhibitor of Lipoprotein(a) Formation: A Randomized Clinical Trial | Cardiology | JAMA
This phase 1 randomized clinical trial evaluates the safety, tolerability, pharmacokinetics, and exploratory pharmacodynamic biomarker effects of muvalaplin in
Related Keywords
Copenhagen
,
Køavn
,
Denmark
,
United States
,
Amsterdam
,
Noord Holland
,
Netherlands
,
Funder
,
Midtjylland
,
Australia
,
Monash
,
South Australia
,
Groningen
,
Helsinki
,
Eteläuomen Läi
,
Finland
,
American
,
Loredana Spoerri
,
Eli Lilly
,
Stephenj Nicholls
,
Novartis
,
Esperion Therapeutics Inc
,
Pharma Group
,
Boehringer Ingelheim
,
Amsterdam Pharmaceuticals
,
Amgen
,
Bristol Myers Squibb
,
Medtronic
,
Monash University
,
Astrazeneca
,
Victorian Heart Institute
,
Medicines Company
,
European Society Of Cardiology Congress
,
Alaska Native
,
Good Clinical
,
Siemens Healthcare Diagnostics
,
Pharmacodynamic Measurements
,
United Kingdom Biobank
,
Copenhagen General Population Study
,
Drs Nicholls
,
Interest Disclosures
,
New Amsterdam Pharma
,
New Amsterdam Pharmaceuticals
,
Envision Pharma Group
,
Sharing Statement
,
European Society
,
Cardiology Congress
,
comparemela.com © 2020. All Rights Reserved.